Status:
COMPLETED
Combined Triple Procedure in Retinal Vein Occlusion (RVO)
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
Retinal Vein Occlusion
Eligibility:
All Genders
21+ years
Phase:
PHASE3
Brief Summary
The aim of this pilot study was to investigate the effects of an intravitreal combination therapy using triamcinolone and bevacizumab in patients with retinal vein occlusion (RVO).
Detailed Description
This prospective study of a case series was conducted in 47 patients (n = 47 eyes; f/m: 21/26; mean age: 66.6 years) with ischemic central RVO (CRVO) (n = 15), non-ischemic CRVO (n = 7), or branch RVO...
Eligibility Criteria
Inclusion
- Ischemic central RVO (CRVO)
- Non-ischemic CRVO
- Branch RVO (BRVO)
Exclusion
- Visual deterioration due to acute or chronic inflammation
- Post trauma
- Macular edema of other origin
- Intravitreal drug treatment within last 4 months
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00805064
Start Date
January 1 2006
End Date
November 1 2008
Last Update
September 27 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.